Global Female Sexual Dysfunction Treatment Market Report and Forecast 2024-2032

Global Female Sexual Dysfunction Treatment Market Outlook

The global female sexual dysfunction treatment market size is expected to grow at a CAGR of 34.2% during the forecast period of 2024-2032 likely to be driven by the rising incidence of the aging female population across the globe. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Female Sexual Dysfunction Treatment Market Overview

The prevalence of female sexual dysfunction increases with an aging population, with approximately 10%  of the women being affected by the age of 49. The incidence doubles up to 22% in women aged 50-65 years and by the age of 77-74, it reaches 47%. The market growth is driven by a significant emphasis on promoting awareness around female sexual health and breaking cultural barriers revolving around the disease. Technological advancements that constitute the development of smart and artificial intelligence-driven devices play a vital role in boosting the market value.

Growth in Smart and Artificial Intelligence Based Devices

The female sexual dysfunction treatment market growth is driven by the rising integration of smart techniques in the treatment landscape. Artificial intelligence is one of the most prominent breakthroughs that is impacting the therapeutic scenario significantly. In recent times, the market has witnessed AI-assisted guidance-based devices, such as The Lioness Vibrator 2.0,  which uses precision sensors and biofeedback. Developed by a United States based femtech start-up, the smart vibrator helps women understand their arousal and sexual response based on data from pelvic muscle contractions.

Application of Novel Therapies

To address a wider section of patients and offer customized and efficient treatment, research activities are witnessing a significant upswing. The development of low-level shockwave therapy, that promotes tissue regeneration and stimulates blood vessel growth via acoustic waves, is a prime example. Developed by United States manufacturer Medispec, Lilycare is an LLSWT device  used in a clinical setting. The device can aid notable growth in the female sexual dysfunction treatment market value.

Rising Drug Development Activities

With deeper understanding of human anatomy and physiology, coupled with rising technical advancements in biopharmaceutical industry, the researchers have dived into developing effective and safe solutions for patients. The growth in drug development and research is anticipated to boost the female sexual dysfunction treatment market share in the upcoming years. In May 2023, Daré Bioscience, Inc.,  along with Strategic Science & Technologies, LLC, announced that their novel topical Sildenafil Cream, 3.6% (Sildenafil Cream) displayed positive topline data from Phase 2b RESPOND study evaluations. The topical cream works by increasing blood flow to the female genitalia and is expected to emerge as a potential treatment for female sexual dysfunction.

According to a February 2023 study performed at an academic research center in the United Kingdom, Kisspeptin , a naturally occurring reproductive hormone stimulating hormone can be used as a safe and potent therapy for women experiencing low sexual desire. As research continues to progress, the market is poised to witness the advent of numerous effective solutions for patients.

Advancements in Alternatives Therapies to Meet the Growing Female Sexual Dysfunction Treatment Market Demand

While treating female sexual dysfunction, a healthcare practitioner must consider several aspects including physical, psychological, genetic, hormonal, environmental, and sociocultural factors. As a result, treatment might be a challenge for many patients. At present, common treatment methods constitute hormone therapy and selective estrogen receptor modulators, such as ospemifene and tibolone along with non-hormonal therapies. However, cultural taboos make it difficult for women to seek appropriate medical treatment. Therefore, there has been rising prevalence and research into alternative therapies such as acupuncture . Research indicates that acupuncture can improve a female’s libido by stimulating the hypothalamic GnRH neurons. As a traditional medical treatment, it offers other advantages such as low cost and fewer side effects as well.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Female Sexual Dysfunction Treatment Market Segmentation

Market Breakup by Indication

• Hypoactive Sexual Desire Disorder (HSDD)

• Arousal Disorder

• Penetration (Sexual Pain) Disorder

• Female Orgasmic Disorder

• Others

Market Breakup by Type

• Counselling and Behavioral Therapy

• Medication
  • Non-Hormonal Therapy
  • Hormonal Therapy

• Others

Market Breakup by Age

• 18-30 Years

• 30-45 Years

• Above 45 Years

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Female Sexual Dysfunction Treatment Market Regional Analysis

With a robust healthcare and research infrastructure, the United States is poised to lead the female sexual dysfunction treatment market share in the forecast period. The presence of key academic institutions and biopharmaceuticals boosts the market share.

Europe is another significant market with multiple emerging start-ups that function by engaging in new-age technologies like artificial intelligence. Chiaro Technology Ltd.,  a United Kingdom based company, designed a medical grade-based egg-shaped device that offers biofeedback on pelvic floor muscle contractions with a connection to a mobile app. The development of such devices is a significant indicator of the growing convergence of digital and smart technologies in healthcare and poised to drive the female sexual dysfunction treatment market value in the forecast period.

The shifting cultural dynamics in the Asia Pacific region is expected to drive notable female sexual dysfunction treatment market growth in the future. Several initiatives aimed at spreading awareness and improving female sexual health are on the rise. Moreover, the rising emphasis on improving healthcare infrastructure to merge the latest technologies in the prevailing medical ecosystem is a major factor anticipated to drive market value in the region.

Global Female Sexual Dysfunction Treatment Market: Competitor Landscape

In September 2023, Biozeus Pharmaceutical S.A.,  an emerging clinical stage biopharmaceutical company based out of Brazil made significant strides in developing a topical treatment for female sexual dysfunction treatment disorder. Aphra, based on a new drug class BZ371 platform, exhibits a distinctive mechanism of local vasodilation and increased local blood flow, without any systemic exposure or side effects. The medication showed positive, safe, and tolerable results in Phase I clinical trials and was advanced to critical Phase II trials. With companies actively increasing their investments on research related activities and new drug development, the market is expected to witness the advent of several effective drugs in the forecast period.

The key features of the female sexual dysfunction treatment market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• AMAG Pharmaceuticals Inc.

• Emotional Brain BV

• Sprout Pharmaceuticals, Inc.

• Pivot Pharmaceuticals Inc.

• Apricus Biosciences, Inc.

• GlaxoSmithKline, Plc

• Pfizer, Inc.

• Merck & Co., Inc.

• Cipla Inc

• Duchesnay Inc.

• Novo Nordisk AS

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Female Sexual Dysfunction Treatment Market Report Snapshots

Female Sexual Dysfunction Treatment Market Size

Female Sexual Dysfunction Treatment Market Regional Analysis

Female Sexual Dysfunction Treatment Companies